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What exactly is synthetic biology? 
Having spent the 20th century taking living things apart, biologists are now 
beginning to put pieces together in new forms. Synthetic biology emerges 
as a new discipline with a few success stories, but no clear direction yet. 
Michael Gross reports. 
Artificial everything: Steven Benner’s group made the first artificial gene encoding a protein 
and has since then moved on to create a whole range of non-natural molecular biology 
ingredients. (Photo: courtesy of Steven Benner.)Life is notoriously difficult to define. 
As our chances of discovering 
extraterrestrial life are gradually 
improving, astrobiology is still 
struggling to define what one should 
be looking for and which of the many 
features of life on Earth are defining for 
life in a more general sense. 
The emerging discipline of synthetic 
biology faces a similar definition 
problem. It is, as it says on the label, 
about synthesizing the living. This 
is a major change of direction, as 
biology has spent the entire 20th 
century following the highly successful 
doctrine of reductionism and dissection 
of organisms into functional units 
down to the biomolecules, in a bid 
to understand what makes them 
tick. Now that biologists have a large 
number of building blocks of life at their 
disposal, they can start putting them 
back together, either to understand the 
higher-order functions (an endeavour 
known as systems biology) or to create 
variations of the existing life forms with 
new or improved functions, which we 
now call synthetic biology. 
It’s in the process of creating life 
from natural and synthetic building 
blocks that the views of synthetic 
biology begin to diverge. Which 
parts of life are the building blocks 
and which are the essence of life? 
One could, for instance, argue that 
life is in the genomes, and the whole 
phenotype is just the toolkit they use 
to survive and replicate. Conversely, 
one could see the organism as the 
essential unit and the genome as its 
data storage facility. Different views 
on the meaning of ‘life’ will lead to 
different definitions of ‘synthetic 
biology’. 
Accordingly, Steven Benner from 
the Westheimer Institute for Science 
and Technology at Gainesville, Florida, 
has observed that there are two 
apparently opposite definitions of 
synthetic biology. Among engineers, 
Benner said at the conference SB5.0 
held at Stanford University in June, 
“synthetic biology seeks to use natural parts of biological systems (like DNA 
fragments or protein biobricks) to create 
assemblies that do things that are 
not done by natural biology, such as 
digital computation or manufacture of 
specialty chemicals”. Among chemists, 
by contrast, “synthetic biology seeks 
to use unnatural molecular parts to do 
things that are done by natural biology”.
Or maybe it’s down to pragmatic 
decisions and everybody just tinkers with 
the bits they can access to synthesize something that appears useful to them. 
In a bid to avoid further philosophical 
confusion, let’s explore some examples 
of research efforts that have sailed under 
the flag of synthetic biology. 
Redirecting metabolism
If the network of chemical reactions 
in a cell, i.e. metabolism, is the most 
important or relevant aspect of life, 
our ability to ‘create’ life has to be 
measured as our ability to change 
metabolism in more comprehensive 
ways than just by overexpressing an 
enzyme here or there. 
An early success story in this respect 
was the engineered pathway leading 
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Close collaboration: Self-assembling fibrils and sheets of RNA can help to keep two proteins 
in close proximity to each other within the bacterial cell and can thereby enhance their 
productivity. In the proof-of-principle example published in Science magazine in July, the RNA 
scaffolds speed up the production of hydrogen which requires the joint activity of the proteins 
ferredoxin and hydrogenase. (Photo: Reprinted with permission from AAAS.)to artemisinic acid, a precursor for 
the malaria drug artemisinin, reported 
in 2006. Researchers led by Jay 
Keasling at the University of California 
in Berkeley created a new junction 
in the metabolic network of baker’s 
yeast (Saccharomyces cerevisiae). By 
introducing additional genes for the 
relevant enzymes, they diverted the 
intermediate farnesyl pyrophosphate, 
en route to ergosterol, to a three-step 
synthesis leading to artemisinic acid, 
which is secreted into the medium at 
concentrations of 100 mg per litre. 
Recently, the group of Pamela 
Silver at Harvard engineered spatial ordering in a bacterial strain genetically 
engineered to produce molecular 
hydrogen. Taking inspiration from 
DNA nanotechnology, the group 
designed RNA strands such that they 
self-assembled into fibrils or into a 
two-dimensional mesh. The strands 
also incorporated two distinct aptamer 
sites, i.e. molecular recognition sites for 
specific targets, recognising the protein 
domains PP7 and MS2. 
Expressing the RNA building blocks 
in the bacteria, the researchers found 
that they self-assemble in vivo in 
the same shapes anticipated in the 
design and previously observed in vitro. Then they also expressed 
the two proteins necessary for 
hydrogen secretion, ferredoxin and 
hydrogenase, as fusion proteins with 
MS2 and PP7, respectively, as there 
are no RNA aptamers available that 
recognise these proteins directly. 
They observed that hydrogen 
production by cells with the RNA 
scaffolds increased up to 48-fold 
compared with the cells that have just 
the proteins in free solution. 
The authors conclude that the spatial 
organisation provided by the RNA 
scaffold has increased the efficiency of 
the hydrogen formation reaction, which 
depends on interaction between the 
two proteins. “The approach provides 
a new way to facilitate the organization 
of reactions within cells. This could 
have major impact in future metabolic 
engineering efforts,” Pamela Silver 
concludes. 
Synthetic genes to synthetic genomes
If one is of the conviction that genes 
are the key to all biological questions 
and the whole phenotype around them 
is just the support system, synthetic 
biology must mean synthetic genes and 
ultimately genomes. 
Steven Benner pioneered this 
version of synthetic biology back in 
1984, when his laboratory at Harvard 
synthesized a gene for an enzyme for 
the first time (a tRNA gene had been 
made previously). From there, Benner 
went on to develop an expanded 
genetic alphabet (AEGIS, Artificially 
Expanded Genetic Information System) 
incorporating artificial bases and an 
expanded set of DNA building blocks. 
Benner’s lab has now established an 
entire molecular biology toolkit around 
the artificial system. In a recent report, 
for instance, the lab describes the 
interaction of restriction enzymes with 
DNA sequences using the expanded 
code (Nucleic Acids Res. (2011), 39, 
3949–3961).
“AEGIS is already being used 
today in the clinic to help personalize 
the care of 400,000 patients each 
year infected with HIV or hepatitis 
virus,” Benner says. “Applications 
being developed include point-of-care 
diagnostics, where doctors will be 
able to identify the infection and write 
a prescription before a patient leaves 
the doctor’s office,” he adds. “For 
the future, AEGIS offers a platform 
to apply the power of evolution to 
the development of new devices in a 
risk-free synthetic biology.”
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Synthesizing life: One of the motivations 
behind attempts to create living entities 
synthetically is the desire to understand 
how life on Earth originated. This field was 
launched by the pioneering experiments 
of Stanley Miller (1930–2007), who showed 
that simulated primeval Earth conditions 
can produce amino acids from simple and 
abundant molecules. (Photo: SCIENCE PHOTO 
LIBRARY.)In the meantime, as has been widely 
reported, genomics pioneer J. Craig 
Venter and the institute named after 
him have synthesized a complete 
bacterial genome and introduced it 
into the empty shell of a bacterial cell 
from which the chromosome had been 
removed, resulting in what Venter 
likes to call the “synthetic cell”. The 
new species, similar to Mycoplasma 
mycoides, on which the artificial 
genome was modelled, has been 
cultivated successfully in the lab. 
“The work at the JCVI follows in 
the best tradition of synthetic organic 
chemistry,” Steven Benner comments. 
“By setting a grand challenge, these 
researchers have shown both what 
is possible and what is difficult in 
whole-genome research, and pushed 
forward the line between these.”
There is a very pragmatic perspective 
on this endeavour based on the 
idea that we only really understand 
genomes when we can go beyond 
reading them and write new ones. In 
that respect, synthetic biology is only at 
the very beginning, as Venter’s artificial 
genome is mostly a carbon copy of the 
Mycoplasma genome, and even the 
error rate in copying is still a problem. 
The artificial life form that was obtained 
in the end could have been produced 
much more easily using established 
methods of genetic engineering. 
On the other hand, the widely 
publicised work has also triggered 
predictable criticism alleging that 
scientists are “playing God” or trying 
to emulate Frankenstein. This was 
arguably an outcome that the authors 
instigated deliberately, witness the 
first word of the title of their paper 
in Science magazine: “Creation.” So 
Venter may well be thinking that he 
is playing God, but in this game he is 
only beginning to learn the rules, and 
it will be a while before he can even 
match the fictional results of Dr Victor 
Frankenstein. 
Genetic networks 
To some it’s the metabolism, to others 
the genome sequence, yet others will 
say it’s neither: the important part 
of life is the network of genes. What 
if they are right — can biologists 
synthesize the complex and many-fold 
interactions between the genes of an 
organism? 
An early effort to introduce synthetic 
genetic networks into a living cell was 
reported by Jeff Hasty and colleagues 
in 2008. These researchers introduced a pattern involving two coupled 
feedback loops into Escherichia 
coli, where one of the gene products 
activates both groups of genes 
(positive feedback), while the other one 
represses both (negative feedback). 
The competition between these two 
effects produced a stable oscillation 
which the researchers could observe 
visually by introducing GFP, so the 
net result of their efforts was bacteria 
flashing green light. Furthermore, 
the researchers could regulate 
the frequency of the oscillation by 
manipulating the concentrations of the 
molecules involved. 
Speaking at the recent SB5.0 
conference, Filippo Menolascina from 
the TeleThon Institute of Genetics and 
Medicine in Naples, Italy, introduced a 
logical next step to the application of 
genetic networks in living cells, namely 
to design networks that can control 
significant parts of cellular function. His 
work in the group of Mario and Diego 
di Bernardo uses a synthetic network 
of five genes established in live yeast 
cultures as a switch. The researchers 
can operate the switch by automatically 
exchanging the glucose in the medium 
for galactose using microfluidics 
devices. Downstream of the switch, 
they used GFP to monitor the outcome 
of the operation (Automatica (2011), 47, 
1265–1270). 
Daisuke Umeno from Chiba 
University, Japan, also reported 
efforts to develop genetic switches 
and circuits using evolutionary design 
(Nucleic Acids Res. (2011), 39, e12). By 
coupling the survival of the host cells to 
the function of the designed switches 
or circuits, the researchers put their 
cells in a ‘sink or swim’ situation which 
achieves highly efficient selection. 
“A single round of ON/OFF selection 
allowed us to enrich genetic circuitry 
with desired specification from variant 
pools, by the factor of 30,000,” Umeno 
says. “This is by far the best efficiency 
ever reported. All the processes were 
conducted purely by liquid handling; 
this allows us to construct hundreds 
of different switches and circuits in 
parallel and by robotic systems.”
Electrified E. coli 
One key element of the continuing 
fusion of biological and technological 
approaches is the need to interact 
with cells electronically. In the fields of 
sequencing and sensing, for instance, 
electronic detection is desirable 
because it massively reduces the complexity of the apparatus required 
on the technology side of the interface. 
The desire to interface living 
cells with electronic equipment 
has long been hindered by the fact 
that electrodes were too large and 
clumsy compared with cells. With the 
development of nanowires, electronics 
finally had a plug on the length scale 
of cellular components, such that even 
different regions of the same nerve cell 
can be contacted separately. However, 
bacterial cells have literally remained 
insulated from the world of electronics 
by their membrane.
The group of Caroline Ajo-Franklin 
at the Lawrence Berkeley National 
Laboratory at Berkeley, California, 
used the electron transfer apparatus 
of an unusual group of bacteria that 
can essentially ‘breathe rocks’, i.e. 
use external solid metal oxides as 
a terminal electron acceptor for 
anaerobic respiration. The group 
expressed three key proteins from the 
electron transfer system of Shewanella 
oneidensis MR-1 in E. coli, namely the 
cytochromes MtrA and MtrC, and the 
outer membrane beta-barrel protein 
MtrB. 
The researchers went on to show 
that the genetically modified bacteria 
could plug this electron transfer system 
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The Lombard effect
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Figure 1. The Lombard effect.
Even if you weren’t aware of the Lombard effect, 
or what it was called, you almost certainly 
 exhibited it the last time you had a conversation 
in a noisy club, at a loud party or on a busy 
street corner with a car or bus passing by. 
(Photograph courtesy of Damon Locks.)into its own redox chemistry and use it 
to reduce external solid minerals, just 
as Shewanella does (Proc. Natl. Acad. 
Sci. USA (2010), 107, 19213–19218). 
Back to the beginning
Apart from the desire to make life a 
little bit different from the version that 
already exists and from the view that 
you can only understand things if 
you can make them, there is a third, 
independent reason for scientists to 
try their hands at synthetic biology, 
namely the attempt to figure out how 
life originated in the first place. 
The ultimate in synthetic biology 
would be to be able to start from 
small molecules and synthesize a 
living, reproducing, evolving entity 
from scratch. Our understanding of 
prebiotic chemistry, and everything 
that then happened until the advent of 
the last common ancestor of today’s 
species, is still far too incomplete to 
allow researchers the slightest hope of 
achieving such a feat. Yet the synthetic 
biology community also includes 
researchers who try to reconstruct 
certain stages on the path towards life. 
For instance, Aniela Wochner from 
the MRC Laboratory of Molecular 
Biology at Cambridge, presented 
work on “reconstructing the RNA 
world” at the SB5.0 meeting. Using 
in vitro evolution techniques, her work 
involves engineering ribozymes that 
can polymerise RNA, a key requirement 
for a self-sufficient RNA world (see also 
Science (2011), 332, 209–212). 
Beyond the design of futuristic new 
life, Steven Benner is also interested in 
the recreation of early life. Thus, parts of 
his research efforts are directed towards 
‘paleogenetics’, i.e. the extrapolation of 
the genes of long-forgotten common 
ancestors, and the expression of 
the proteins corresponding to these 
genes. With this approach, Benner’s 
group has addressed questions such 
as the thermophilic tendencies of 
early bacteria and the biochemistry of 
ruminant digestion.
In creating new life and recreating 
how life came to be here, while tackling 
unsolved mysteries around its functional 
mechanisms, it sounds as though 
synthetic biology, taking over from the 
classic 20th century reductionist and 
analytical approach, has enough work 
to do for the rest of this century. 
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web page 
at www.michaelgross.co.ukWhat is it? This year marks the 100 
year anniversary of the discovery of 
the Lombard effect, an involuntary 
vocal response by speakers to the 
presence of background noise. In 
the century since its discovery, this 
phenomenon has surely achieved 
importance far beyond what its 
discoverer could have ever imagined. 
In the simplest terms, the Lombard 
effect is an increase in vocal 
amplitude in response to an increase 
in background noise. Although most 
people are probably not aware of it, 
we all know the Lombard effect — 
just think of the last time you tried to 
engage in a conversation in a noisy 
pub or at a boisterous party (Figure 1).
How did it get its name? In 1911, 
a French otolaryngologist named 
Étienne Lombard published 
an article entitled “Le signe de 
l’élévation de la voix”, which 
described an interesting observation 
he made while working at the 
Hôpital Lariboisière in Paris (Figure 2). 
Lombard had noticed that when 
a patient who was engaged in 
conversation was presented with an 
intense noise, he would elevate the 
level of his speaking voice. Lombard 
perceived that the patient did not 
seem aware of this change in vocal 
amplitude, and concluded this was 
an involuntary reflex: he thought 
that this “sign of the elevation of the 
voice” could be used as a tool to 
ferret out malingerers pretending to 
be deaf in order to shirk their work 
duties, or make false claims of injury.
The discovery was dubbed the 
‘Lombard sign’ by Lombard’s student 
in a subsequent publication and the 
terminology was soon adopted by 
others. Because of the involuntary 
nature of the phenomenon, some 
authors began using the term 
‘Lombard reflex’. Both names are 
still sometimes used, but as the 
phenomenon is not a true reflex 
the most common and generally 
accepted term is the ‘Lombard 
effect’.How does it work? Although the 
adjustment of vocal intensity 
happens involuntarily when 
background noise levels change, 
the phenomenon is not truly a reflex. 
Much of what we do know about 
how the Lombard effect works at a 
neural level comes from comparative 
work on non-human primates 
and other mammals. From these 
studies we learn that the essential 
circuits responsible for the Lombard 
effect are located in the brainstem. 
Specifically, sets of audio-vocal 
neurons in the periolivary region and 
the pontine reticular formation are 
the most likely candidates for the 
integration of vocal production and 
auditory perception that is necessary 
for the Lombard effect. 
As mentioned above, however, 
the Lombard effect is not a true 
reflex, in that it is not controlled by 
a simple reflex arc. One clue that 
higher cortical areas are involved is 
that the effect, although involuntary, 
can be modulated by social context 
and can be inhibited with training 
involving feedback from a different 
sensory modality. Although the 
Lombard effect is robust and simply 
instructing speakers to keep their 
voice level constant does little to 
inhibit it, when speakers are provided 
with visual feedback displaying 
their vocal intensity in real time, it is 
possible to train a speaker to inhibit 
the rise in voice amplitude. 
While the term ‘Lombard effect’ 
generally describes only the change 
in vocal amplitude, the effect is 
very often accompanied by a suite 
of other vocal changes, including 
a rise in fundamental frequency, a 
